The short version is this: Neuralink has a speech trial, it's recruiting in Dallas, and it isn't the cursor product. The VOICE study is on ClinicalTrials.gov as NCT07224256, an early feasibility trial of a robotically implanted brain-computer interface for communication restoration. The page lists the site as The University of Texas Southwestern Medical Center in Dallas. Status: recruiting. Estimated enrollment: six. Start date: 3 October 2025. Primary completion: October 2028. Completion: October 2031. Those are the registry numbers. They aren't a product launch.